Medtronic shares took off after the company posted better financial results than expected, boosted by what management called a “robust” volume of medical procedures.

Medtronic's cardiovascular sales rise 10.8% to $3.44 bln CEO emphasizes on cardiology and neuroscience M&A CFO confirms diabetes business to go public in 2026 Nov 18 (Reuters) - Medtronic (MDT.N), ...

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase ...

Minnesota medtech giant Medtronic found positive momentum Tuesday morning as it faced down what top executives see as a critical moment for the maker of innovative medical devices and procedures for ...

Medtronic’s pulsed field ablation business took off last quarter as competition in the space continues to heat up nearly two years after products first launched. PFA sales grew by more than 300% year ...

Medtronic officials today said the planned separation of its Diabetes business (MiniMed) remains on track, with future offerings also on the horizon. On the company’s second-quarter earnings call, CFO ...

Under this partnership, the Minze Diary Pod - an automated bladder diary slution - will be offered as part of the SNM care pathway, enabling clinicians and patients to gather richer, more objective ...

Minze Health NV signed a three-year agreement with Medtronic plc to bring its Minze Diary Pod, an app-controlled automated urine collection device, to markets across the EMEA region. The partnership ...

Minze Health, a digital health company, today announced a three-year agreement with Medtronic, a global leader in healthcare technology, to commercialize the Minze Diary Pod across the EMEA region.

Patients with bladder control symptoms who receive a Medtronic Sacral Neuromodulation Device will now have access to the Minze Diary Pod Under this partnership, the Minze Diary Pod – an automated ...